AnaptysBio, Inc. (NASDAQ: ANAB) reported Q1 EPS of ($1.84), $0.88 worse than the analyst estimate of ($0.96). Revenue for the quarter came in at $25.56 million versus the consensus estimate of $23.04 million.

For earnings history and earnings-related data on AnaptysBio, Inc. (ANAB) click here.